Salah Nermin, Abd El Dayem Soha M, Fawaz Lobna, Ibrahim Marwa
Pediatrics Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
J Pediatr Endocrinol Metab. 2013;26(3-4):247-55. doi: 10.1515/jpem-2012-0074.
To determine the predictors of growth response to growth hormone treatment in a group of isolated idiopathic growth hormone (GH).
477 GH deficient (GHD) children with GH therapy were included in the study. Patients were followed up for a minimum of 1 year and up to 6 years. Multiple linear regressions were performed to identify predictors of growth response to rhGH in the first 4 years of treatment.
In the first year, three significant predictors of growth were identified: GH peak [ln (ug/L)], age of onset of therapy and target height-height SDS. In the second and third years of therapy, growth velocity (GV) was both significantly and positively correlated to the GV (cm/year) of the previous year.
Prediction models offer a valuable tool for individualization and assuring adherence to rhGH and thus a cost effective treatment, which is the ultimate goal of GH therapy.
确定一组孤立性特发性生长激素(GH)缺乏患者对生长激素治疗生长反应的预测因素。
477例接受生长激素治疗的生长激素缺乏(GHD)儿童纳入本研究。对患者进行了至少1年至6年的随访。采用多元线性回归分析确定治疗前4年生长激素对重组人生长激素(rhGH)反应的预测因素。
在第一年,确定了三个显著的生长预测因素:生长激素峰值[ln(μg/L)]、治疗开始年龄和靶身高-身高标准差分值(SDS)。在治疗的第二年和第三年,生长速度(GV)与上一年的生长速度(厘米/年)均呈显著正相关。
预测模型为个体化和确保rhGH治疗的依从性提供了有价值的工具,从而实现具有成本效益的治疗,这是生长激素治疗的最终目标。